| 发明名称 |
USE OF CARDIOTROPHIN-1 FOR THE TREATMENT OF METABOLIC DISEASES |
| 摘要 |
The invention is related to the use of cardiotrophin-1 (CT-1) for the treatment of obesity and associated disorders: hyperglycaemias, insulin resistance, development of type 2 diabetes and dyslipemias and given its anorexigenic role, fat oxidation stimulant, hypoglycaemic, sensitizing agent of the action of insulin on a skeletal muscle level and inhibitor of the intestinal transport of glucose by enterocytes.
|
| 申请公布号 |
US2011293562(A1) |
申请公布日期 |
2011.12.01 |
| 申请号 |
US201013201431 |
申请日期 |
2010.02.10 |
| 申请人 |
PRIETO VALTUENA JESUS MARIA;BUSTOS DE ABAJO MATILDE;MORENO ALIAGA MARIA JESUS;PROYECTO DE BIOMEDICINA CIMA, S.L. |
发明人 |
PRIETO VALTUENA JESUS MARIA;BUSTOS DE ABAJO MATILDE;MORENO ALIAGA MARIA JESUS |
| 分类号 |
A61K38/20;A61K31/7088;A61K35/00;A61K38/28;A61P3/00;A61P3/04;A61P3/06;A61P3/10 |
主分类号 |
A61K38/20 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
